Sarepta Therapeutics, Inc. (227) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Form of Exchange Agreement
(Filed With SEC on March 3, 2023)
-
Indenture, dated as of September 16, 2022, by and between Sarepta Therapeutics, Inc. and U. S. Bank Trust Company, National Association (including the form of the 1.250%...
(Filed With SEC on September 19, 2022)
-
Purchase Agreement, dated as of September 13, 2022, among Sarepta Therapeutics, Inc. and the several Initial Purchasers named in Schedule 1 thereto for whom Goldman, Sachs & Co....
(Filed With SEC on September 19, 2022)
-
Purchase Agreement, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Michael A. Chambers Living Trust
(Filed With SEC on September 19, 2022)
-
Underwriting Agreement, October 13, 2021 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse...
(Filed With SEC on October 15, 2021)
-
First Amendment dated September 24, 2020 to Loan Agreement among Sarepta Therapeutics, Inc., BioPharma Credit PLC and BioPharma Credit Investments V (Master) LP dated December 13,...
(Filed With SEC on November 5, 2020)
-
Amendment No. 1 to the Sarepta Therapeutics, Inc. Amended and Restated 2013 Employment Stock Purchase Plan (as Amended and Restated on June 27, 2016)
(Filed With SEC on August 7, 2019)
-
Underwriting Agreement, March 5, 2019 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named...
(Filed With SEC on March 7, 2019)
-
Amendment to Restricted Stock Award Agreement between Douglas S. Ingram and Sarepta Therapeutics, Inc. dated December 17, 2018
(Filed With SEC on February 28, 2019)